Navigation Links
Medpace Strengthens Presence in Central Europe
Date:8/21/2007

CINCINNATI and PRAGUE, Czech Republic, Aug. 21 /PRNewswire/ -- Medpace, Inc., a leading global full-service contract research organization, today announced it has completed the acquisition of Monax s.r.o., a regional contract research organization (CRO) headquartered in Prague, Czech Republic. This move strengthens the Medpace presence in Central Europe and expands its capacity to provide full service clinical research management within the Czech Republic and Slovakia. Petr Potuznik, MD, the founder of Monax, will continue to lead Medpace clinical operations for the region.

"We are excited to welcome the Monax team to the Medpace family," said August Troendle, MD, Medpace Chief Executive Officer. "The expertise of Dr. Petr Potuznik and his highly trained team fit perfectly within our strategic global expansion plan."

"We have worked closely with Medpace in the past and found that our companies shared a high level of expertise and commitment to quality," said Potuznik. "Becoming part of the Medpace group allows the Monax team to grow and expand our presence and capabilities throughout the region."

About Medpace

Medpace is a global, research-based drug development company led by top therapeutic and regulatory experts who are driven to further the advancement of pharmaceutical agents for use in cardiology, metabolism, and oncology. Medpace has assembled the industry's most experienced and therapeutically focused team to execute at every level of the company's operations, providing complete and seamless drug development services.

Through specialized regulatory expertise and therapeutically focused clinical operations, Medpace creates strategic partnerships with pharmaceutical and biotechnology companies to provide the most efficient and cost-effective path to drug development - from program planning and execution to product approval.

With more than 500 employees and clinical trial experience in nearly 40 countries, Medpace has the global reach and capability to conduct studies and navigate regulatory requirements worldwide within the core therapeutic areas of cardiology, metabolism, and oncology.

The Medpace group of companies also includes

Imagepace - a centralized imaging laboratory with expertise in cIMT

Medpace Reference Laboratory - a centralized lab with therapeutically specialized testing

Medpace Clinical Pharmacology - a Phase I/IIa unit scheduled to open in Q1, 2008.

Contact: Stephanie Lusk 513-579-9911 x1102


'/>"/>
SOURCE Medpace, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. BIO 2007: Wisconsin makes its presence felt
2. TDS trades markets to gain Duluth presence
3. West Coast VC Establishes Midwest Presence in Madison
4. Sony Bets Heavy on Wisconsin Digital Entertainment Presence
5. Madison start-up Central Signal gets $350K grant
6. Will wireless Internet bypass the central city?
7. Norlight to expand fiber network into central Illinois
8. Centralization mania takes over
9. Meterologix Media Division acquired by Madison-based Weather Central
10. Weather Central launches second satellite
11. Development of an NK2 neuropeptide receptor binding assay using LEADseeker Multimodality Imaging System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... 5, 2016 Australian-US drug discovery and development company, ... appointment of a new Chairman, Mr John O,Connor , ... immediately. James Garner , has also been ... former Acting CEO, Mr Iain Ross , will resume ... --> James Garner , has also been formally appointed ...
(Date:2/4/2016)... , February 4, 2016 - New FDA action ... - New FDA action date of July 22, ... July 22, 2016   - ... in the past decade indicated for the treatment of signs and symptoms of ... has the potential to be the only product approved in the U.S. in ...
(Date:2/4/2016)... ... February 04, 2016 , ... Shimadzu Scientific Instruments ... host live demos and poster sessions, and present on the analysis of mycotoxins ... place March 6 to 10 at the Georgia World Congress Center in Atlanta, ...
(Date:2/4/2016)... -- Beike Biotechnology, the Shenzhen ... in late 2015 to mark their successful combined efforts ... --> --> The signing, ... Therapy" was hosted by the Shenzhen Cell Bank and ... Beike Biotechnology Co., Ltd. Shenzhen,s ...
Breaking Biology Technology:
(Date:2/2/2016)... , Feb. 2, 2016 This ... the bioinformatic market by reviewing the recent advances ... tools that drive the field forward. Includes forecast ... Identify the challenges and opportunities that exist ... and software solution developers, as well as IT ...
(Date:2/1/2016)... -- Rising sales of consumer electronics coupled ... gesture control market size through ... electronics coupled with new technological advancements to drive global ... through 2020   --> Rising ... to drive global touchfree intuitive gesture control market ...
(Date:1/25/2016)... 2016   Unisys Corporation (NYSE: UIS ) today ... (JFK) International Airport, New York City , to ... attempting to enter the United States using ... pilot testing of the system at Dulles last year. ... JFK during January 2016. --> pilot testing of ...
Breaking Biology News(10 mins):